About FDA

Office of Prescription Drug Promotion (OPDP) Launches

Please see draft guidance entitled Providing Regulatory Submissions in Electronic and Non-Electronic Format - Promotional Labeling and Advertising Materials for Human Prescription Drugs for recommendations on how to submit.

Please note that implementaton for the new eCTD M1 is still pending.  Please refer to the eCTD webpage for details and timing of implementation.

Note: For any time sensitive materials, please confirm receipt of the submission by OPDP with a phone call to the OPDP project manager at 301-796-1200.

For questions regarding this information, please email CDER-OPDP-RPM@FDA.HHS.GOV.



Page Last Updated: 04/21/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.